Strong or moderate HER-2 staining (2+ or 3+) at diagnosis persisted in every case after chemotherapy although HER-2 positivity (3+ cases only) changed in nine cases: five 2+ tumours were scored 3+ at operation and four 3+ tumours reverted to 2+ at surgery. This evidence concerns the gene ERBB2 and neoplasm.